IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,782,249 | +109.7% | 238,327 | +149.4% | 0.01% | +116.7% |
| Q2 2023 | $1,803,236 | +114.2% | 95,561 | -56.4% | 0.01% | +100.0% |
| Q1 2023 | $841,740 | +22.0% | 219,203 | +57.6% | 0.00% | +50.0% |
| Q4 2022 | $689,728 | +122.5% | 139,058 | +114.3% | 0.00% | +100.0% |
| Q3 2022 | $310,000 | -14.6% | 64,900 | -19.5% | 0.00% | 0.0% |
| Q2 2022 | $363,000 | -23.1% | 80,641 | -18.7% | 0.00% | – |
| Q1 2022 | $472,000 | +38.4% | 99,216 | +116.0% | 0.00% | – |
| Q4 2021 | $341,000 | -18.2% | 45,929 | -37.6% | 0.00% | – |
| Q3 2021 | $417,000 | +368.5% | 73,631 | +446.7% | 0.00% | – |
| Q2 2021 | $89,000 | -74.3% | 13,469 | -74.9% | 0.00% | -100.0% |
| Q4 2020 | $346,000 | +188.3% | 53,713 | +105.2% | 0.00% | 0.0% |
| Q2 2020 | $120,000 | +500.0% | 26,171 | +344.6% | 0.00% | – |
| Q1 2020 | $20,000 | -92.9% | 5,886 | -94.3% | 0.00% | -100.0% |
| Q1 2019 | $281,000 | -43.8% | 103,695 | -0.4% | 0.00% | -25.0% |
| Q4 2018 | $500,000 | +134.7% | 104,120 | +362.2% | 0.00% | +100.0% |
| Q3 2018 | $213,000 | -76.8% | 22,528 | -76.1% | 0.00% | -75.0% |
| Q2 2018 | $919,000 | +1457.6% | 94,407 | +922.8% | 0.01% | – |
| Q4 2017 | $59,000 | -63.6% | 9,230 | -56.5% | 0.00% | -100.0% |
| Q3 2017 | $162,000 | -33.9% | 21,233 | -82.3% | 0.00% | -50.0% |
| Q4 2016 | $245,000 | +75.0% | 120,173 | +130.9% | 0.00% | 0.0% |
| Q3 2016 | $140,000 | +55.6% | 52,052 | +77.5% | 0.00% | +100.0% |
| Q2 2016 | $90,000 | -68.0% | 29,325 | -11.0% | 0.00% | -75.0% |
| Q1 2016 | $281,000 | +35.1% | 32,965 | +115.0% | 0.00% | +100.0% |
| Q4 2015 | $208,000 | -43.0% | 15,335 | -59.7% | 0.00% | -60.0% |
| Q3 2015 | $365,000 | +288.3% | 38,024 | +263.4% | 0.01% | +400.0% |
| Q1 2015 | $94,000 | -50.0% | 10,462 | -66.0% | 0.00% | -66.7% |
| Q4 2014 | $188,000 | -64.4% | 30,796 | -38.2% | 0.00% | -62.5% |
| Q3 2014 | $528,000 | +126.6% | 49,863 | +153.6% | 0.01% | +100.0% |
| Q2 2014 | $233,000 | +24.6% | 19,659 | +57.3% | 0.00% | +33.3% |
| Q1 2014 | $187,000 | -72.2% | 12,498 | -72.7% | 0.00% | -70.0% |
| Q4 2013 | $672,000 | +95.3% | 45,780 | +126.5% | 0.01% | +42.9% |
| Q3 2013 | $344,000 | +473.3% | 20,213 | +459.6% | 0.01% | +600.0% |
| Q2 2013 | $60,000 | – | 3,612 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |